Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Mechanism of Action/Pathway Profiles
Molecular Pathways in Cancer Are Increasingly Being Exploited
Mechanism of Action/Pathway Profiles
Read More ›
Case Presentation: Targeted Therapy in Metastatic Melanoma
Mechanism of Action/Pathway Profiles
Read More ›
The Ultimate Target of Personalized Oncology Treatment: Improving the Lives of Our Patients
Mechanism of Action/Pathway Profiles
,
Letter to Our Readers
Read More ›
Confirming Diagnoses and Identifying Biomarkers Linked to Targeted Treatments with the bioT3 Approach
By
Ralph V. Boccia, MD, FACP
Interview with the Innovators
,
Mechanism of Action/Pathway Profiles
Read More ›
Two Cases of Triple-Hit Lymphoma: A Call for Imperative MYC, BCL2, and BCL6 Testing by FISH in Aggressive Lymphomas
By
Daniel C. McFarland, DO
;
Joshua Brody, MD
;
Joseph Tripodi, MsS
;
Issa Leonard, BS
;
Vesna Najfeld, PhD
Mechanism of Action/Pathway Profiles
Read More ›
Molecular Therapy Beyond Sorafenib in HCC: New Pathways, Targets Being Explored
Mechanism of Action/Pathway Profiles
Read More ›
Idelalisib and Ibrutinib Are Promising B-Cell Receptor Signaling Inhibitors in B-Cell Malignancies
Mechanism of Action/Pathway Profiles
Read More ›
Novel Approaches in the Treatment of Hematologic Malignancies Utilizing Bendamustine
Mechanism of Action/Pathway Profiles
Read More ›